Manufacturing News of Note—Halix boosts viral vector production; FDA reassures patients taking blood pressure meds


Here is some news of note for the week: 

> Halix, a CDMO in the Netherlands, says it completed a five-level production facility for making viral vaccines and viral vectors as well as protein manufacturing at its site in Leiden. Release

> The FDA issued a statement to try to ease consumer concerns over the risks of contaminated sartan drugs. Statement

> The Novo Nordisk Foundation has awarded $27 million in grants to help the improve pharmaceutical processes to be easier on the environment. Release

> CDMO Sterling Pharma Solutions has started large-scale production of silica particles. Release

> Biocon says its insulin facility in Malaysia has been approved by the EU. Release

> Orano Med says it is investing €15 million in facilities in France and the U.S. to develop treatments using radioactive properties. Story

Suggested Articles

Life sciences companies have pivoted quickly during COVID-19 - Syneos Health® is supporting more than 80 active COVID-19 projects, including vaccines.

New York's Covaxx has signed on with three South American nations to provide 140 million doses of its early-stage COVID-19 vaccine.

CureVac has tapped Wacker to help produce 100 million doses of its mRNA-based COVID-19 vaccine at its Amsterdam facility.